| Dr Dean Brian Levitan, MD | |
|
1700 S Court St, Suite B, Visalia, CA 93277-4929 | |
| (559) 741-1202 | |
| (559) 741-0123 |
| Full Name | Dr Dean Brian Levitan |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 46 Years |
| Location | 1700 S Court St, Visalia, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528014685 | NPI | - | NPPES |
| 00G471940 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | G47194 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaweah Delta Medical Center | Visalia, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Visalia Women's Specialty Medical Group, Inc | 7517904188 | 3 |
News Archive
Resverlogix Corp. today announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE.
Alkermes, Inc. today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders. The study will assess the safety and efficacy of multiple doses of ALKS 33 in patients with alcohol dependence and is designed to further define the clinical profile of ALKS 33.
Got lots of fast food restaurants and other outlets that sell junk food in your neighborhood? Then your teen is more likely to nosh regularly on burgers and fries and wash them down with a soda.
Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that causes multiple sclerosis (MS) may be stopped or slowed down.
The Kaiser Family Foundation launched a web-based tool, called "Global Health Interventions: A Review of Evidence," as part of an effort to provide policy-relevant and accessible information on the efficacy of key global health interventions, including the strength of the evidence.
› Verified 5 days ago
| Entity Name | Visalia Women's Specialty Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386709202 PECOS PAC ID: 7517904188 Enrollment ID: O20050414000868 |
News Archive
Resverlogix Corp. today announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE.
Alkermes, Inc. today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders. The study will assess the safety and efficacy of multiple doses of ALKS 33 in patients with alcohol dependence and is designed to further define the clinical profile of ALKS 33.
Got lots of fast food restaurants and other outlets that sell junk food in your neighborhood? Then your teen is more likely to nosh regularly on burgers and fries and wash them down with a soda.
Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that causes multiple sclerosis (MS) may be stopped or slowed down.
The Kaiser Family Foundation launched a web-based tool, called "Global Health Interventions: A Review of Evidence," as part of an effort to provide policy-relevant and accessible information on the efficacy of key global health interventions, including the strength of the evidence.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dean Brian Levitan, MD 1700 S Court St, Suite B, Visalia, CA 93277-4929 Ph: (559) 741-1202 | Dr Dean Brian Levitan, MD 1700 S Court St, Suite B, Visalia, CA 93277-4929 Ph: (559) 741-1202 |
News Archive
Resverlogix Corp. today announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE.
Alkermes, Inc. today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders. The study will assess the safety and efficacy of multiple doses of ALKS 33 in patients with alcohol dependence and is designed to further define the clinical profile of ALKS 33.
Got lots of fast food restaurants and other outlets that sell junk food in your neighborhood? Then your teen is more likely to nosh regularly on burgers and fries and wash them down with a soda.
Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that causes multiple sclerosis (MS) may be stopped or slowed down.
The Kaiser Family Foundation launched a web-based tool, called "Global Health Interventions: A Review of Evidence," as part of an effort to provide policy-relevant and accessible information on the efficacy of key global health interventions, including the strength of the evidence.
› Verified 5 days ago
Dr. David J. Borge, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 501 North Bridge Street, Visalia, CA 93291 Phone: 559-734-1939 Fax: 559-734-4384 | |
Karen M Barbosa, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2611 N Dinuba Blvd, Visalia, CA 93291 Phone: 559-733-6342 | |
Dr. Nicholai J Weibell, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1700 S Court St, Suite B, Visalia, CA 93277 Phone: 559-741-1202 Fax: 559-741-0123 | |
Dr. Robert M Ayers, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 North Bridge Street, Visalia, CA 93291 Phone: 559-734-1939 Fax: 559-734-4384 | |
Brian Lynn Acord, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2611 N Dinuba Blvd, Visalia, CA 93291 Phone: 559-733-6342 | |
George Blaine Lake, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Willow Plz, 201, Visalia, CA 93291 Phone: 559-627-9284 Fax: 559-713-0965 | |
Dr. Hoang U Le, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 N. Bridge Street, Visalia, CA 93291 Phone: 559-734-1939 Fax: 559-734-4384 |